- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03949179
Optimizing Management of Low Back Pain Through the Pain and Disability Drivers Management Model
Optimizing Management of Low Back Pain Through the Pain and Disability Drivers Management Model: Study Protocol for a Feasibility Trial
This study aims to determine the feasibility of conducting a future randomized controlled trial to collect preliminary data on the effectiveness of a previously validated approach that takes into account all the pain and disability vectors associated with low back pain - the Pain and Disability Drivers Management Model (PDDM).
The overall objective is to provide data to assess the feasibility of implementing a future randomized clinical trial to evaluate the impact of the PDDM on the management of non-specific LBP in a clinical setting and to explore the short-term effect of using the model on patient's clinical outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Non-specific mechanical low back pain (LBP) is highly prevalent, recurrent and is a leading cause of disability worldwide. Despite increased efforts in improving care, the self-reported levels of disability in individuals with LBP have not improved in the last decade. In order to more effectively manage LBP through non-pharmacological approaches, evidence endorses the use of classification systems to support diagnosis and guide treatments. However, this approach to care is not without limitations and a more comprehensive and broader perspective is needed. Hence, we recently proposed and validated the Low Back Pain and Disability Drivers Management (PDDM) model, which aims to identify the domains influencing pain and disability to create a profile or phenotype to guide clinical decisions. The objective of this study is to assess the feasibility of conducting a trial and to gather preliminary effect outcomes of the intervention in clinical setting.
Methods: The design is a prospective single arm experimental design. Physiotherapists (PTs) working with a population suffering from musculoskeletal disorders and patients presenting with non-specific mechanical LBP from two different clinical settings will be recruited. The intervention consists of a one-day training workshop for PTs on using the PDDM to guide management decisions. PTs will then perform a 6-weeks follow-up with their participating patients. This feasibility study will assess recruitment and retention rates as well as PTs' acceptability and patients' satisfaction outcomes related to the intervention. Preliminary effect outcomes will also be gathered.
Discussion: This study will inform the feasibility and acceptability of the intervention and gather preliminary outcomes to conduct a future randomized controlled trial to measure the effectiveness of the intervention in managing non-specific mechanical LBP.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H2B 1J9
- Réseau de clinique PhysioExtra
-
Sherbrooke, Quebec, Canada, J1H 5H3
- CIUSSS de l'Estrie - CHUS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients:
- Patients presenting with non-specific LBP according to the assessment conducted by the PT
Description
Inclusion Criteria:
Clinicians:
- be working with a population suffering from musculoskeletal disorders such as LBP and have a valid license to practice physiotherapy in the province of Quebec
- agree to participate to the one-day training workshop (intervention)
- assess and initiate treatment of their patients presenting with non-specific LBP guided by our newly developed model
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pain and Disability Drivers Management model
Participating clinicians will use the PDDM model to guide assessment and treatment of their patients for a 6-weeks period.
|
The Low Back Pain and Disability Drivers Management (PDDM) model aims to identify the domains influencing pain and disability to guide clinical decisions.
The model is composed of five domains upon which the clinician can base his assessment and orientate treatment allocation and includes: 1) nociceptive pain drivers (i.e., somatic, inflammatory or mixed pain), 2) nervous system dysfunction (NSD) drivers (i.e., sensitization of the peripheral and/or central nervous system), 3) comorbidity drivers (i.e., physical and/or mental health comorbidities), 4) cognitive-emotional drivers (i.e., maladaptive cognitions and/or behaviors) and 5) contextual drivers (i.e., occupational-related and social environmental contextual drivers).
This profiling will inform and lead the clinician's treatment approach based on the combined contribution of each domain driving the experience of pain and disability.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of implementation
Time Frame: T1: clinician's baseline.
|
Recruitment rate: % of eligible clinicians who enrolled in the study (T1)
|
T1: clinician's baseline.
|
|
Feasibility of implementation
Time Frame: T1: clinician's baseline; T3 (6 weeks)
|
Retention rate: % of contacted clinicians who accepted to participate and report data (T3-T1)
|
T1: clinician's baseline; T3 (6 weeks)
|
|
Clinician's acceptability of the workshop
Time Frame: T1: clinician's baseline (after the workshop)
|
Assessed via semi-structured phone interviews.
It includes the clinician's appreciation of the training.
|
T1: clinician's baseline (after the workshop)
|
|
Clinician's acceptability of the intervention
Time Frame: T3 (6 weeks)
|
Assessed via semi-structured phone interviews and include clinician's perception of suitability of the assessment procedures to refine the diagnosis and to target adequate treatment.
|
T3 (6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nociceptive pain drivers : Change in Brief Pain Inventory (BPI) scores at 6 weeks
Time Frame: At T2: patient initial visit; T3: +6 weeks after initial visit
|
Change in BPI scores measured at T2 and T3 (T3-T2)
|
At T2: patient initial visit; T3: +6 weeks after initial visit
|
|
Nervous system dysfunction drivers: Change in Pain Detect Questionnaire scores at 6 weeks
Time Frame: At T2: patient initial visit; T3: +6 weeks after initial visit
|
Change in Pain Detect Questionnaire scores measured at T2 and T3 (T3-T2)
|
At T2: patient initial visit; T3: +6 weeks after initial visit
|
|
Nervous system dysfunction drivers: Change in Central Sensitization Index (CSI) scores at 6 weeks
Time Frame: At T2: patient initial visit; T3: +6 weeks after initial visit
|
Change in CSI scores measured at T2 and T3 (T3-T2)
|
At T2: patient initial visit; T3: +6 weeks after initial visit
|
|
Cognitive-emotional drivers: Change in StartBackTool (SBT) scores at 6 weeks
Time Frame: At T2: patient initial visit; T3: +6 weeks after initial visit
|
Change in SBT scores measured at T2 and T3 (T3-T2)
|
At T2: patient initial visit; T3: +6 weeks after initial visit
|
|
Contextual drivers: Change in Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) scores at 6 weeks
Time Frame: At T2: patient initial visit; T3: +6 weeks after initial visit
|
Change in OMPSQ scores measured at T2 and T3 (T3-T2)
|
At T2: patient initial visit; T3: +6 weeks after initial visit
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Yannick Tousignant-Laflamme, PhD, School of Rehabilitation, University of Sherbrooke
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MP-31-2019-3131
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.